Fig. 9. Schematic of defective BMPR1A signaling in vascular smooth muscle cells and pericytes. Deletion of BMPR1A results in decreased MMP9 and MMP2 activities in VSMCs, and decreased MMP2 activity in pericytes, culminating in reduced proliferation and apoptosis, respectively.